Cargando…

Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation

Repair of hyaline cartilage remains a huge challenge in clinic because of the avascular and aneural characteristics and the paucity of endogenous repair cells. Recently, tissue engineering technique, possessing unique capacity of repairing large tissue defects, avoiding donor complications and two-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, You-Rong, Zhou, Zhu-Xing, Zhang, Ji-Ying, Yuan, Fu-Zhen, Xu, Bing-Bing, Guan, Jian, Han, Chao, Jiang, Dong, Yang, Yan-Yu, Yu, Jia-Kuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839338/
https://www.ncbi.nlm.nih.gov/pubmed/31737612
http://dx.doi.org/10.3389/fchem.2019.00745
_version_ 1783467400270708736
author Chen, You-Rong
Zhou, Zhu-Xing
Zhang, Ji-Ying
Yuan, Fu-Zhen
Xu, Bing-Bing
Guan, Jian
Han, Chao
Jiang, Dong
Yang, Yan-Yu
Yu, Jia-Kuo
author_facet Chen, You-Rong
Zhou, Zhu-Xing
Zhang, Ji-Ying
Yuan, Fu-Zhen
Xu, Bing-Bing
Guan, Jian
Han, Chao
Jiang, Dong
Yang, Yan-Yu
Yu, Jia-Kuo
author_sort Chen, You-Rong
collection PubMed
description Repair of hyaline cartilage remains a huge challenge in clinic because of the avascular and aneural characteristics and the paucity of endogenous repair cells. Recently, tissue engineering technique, possessing unique capacity of repairing large tissue defects, avoiding donor complications and two-stage invasive surgical procedures, has been developed a promising therapeutic strategy for cartilage injury. In this study, we incorporated low-molecular-weight heparin (LMWH) into carboxymethyl chitosan-oxidized chondroitin sulfate (CMC-OCS) hydrogel for loading transforming growth factor-β3 (TGF-β3) as matrix of peripheral blood mesenchymal stem cells (PB-MSCs) to construct tissue-engineered cartilage. Meanwhile, three control hydrogels with or without LMWH and/or TGF-β3 were also prepared. The gelling time, microstructures, mechanical properties, degradation rate, cytotoxicity, and the release of TGF-β3 of different hydrogels were investigated. In vitro experiments evaluated the tri-lineage differentiation potential of PB-MSCs, combined with the proliferation, distribution, viability, morphology, and chondrogenic differentiation. Compared with non-LMWH-hydrogels, LMWH-hydrogels (LMWH-CMC-OCS-TGF-β3) have shorter gelling time, higher mechanical strength, slower degradation rate and more stable and lasting release of TGF-β3. After two weeks of culture in vitro, expression of cartilage-specific genes collagen type-2 (COL-2) and aggrecan (AGC), and secretion of glycosaminoglycan (GAG), and COL-2 proteins in LMWH-CMC-OCS-TGF-β3 group were significantly higher than those in other groups. COL-2 immunofluorescence staining showed that the proportion of COL-2 positive cells and immunofluorescence intensity in LMWH-CMC-OCS-TGF-β3 hydrogel were significantly higher than those in other groups. The LMWH-CMC-OCS-TGF-β3 hydrogel can slowly release TGF-β3 in a long term, and meanwhile the hydrogel can provide a biocompatible microenvironment for the growth and chondrogenic differentiation of PB-MSCs. Thus, LMWH functionalized CMC-OCS hydrogels proposed in this work will be beneficial for constructing functional scaffolds for tissue-engineered cartilage.
format Online
Article
Text
id pubmed-6839338
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68393382019-11-15 Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation Chen, You-Rong Zhou, Zhu-Xing Zhang, Ji-Ying Yuan, Fu-Zhen Xu, Bing-Bing Guan, Jian Han, Chao Jiang, Dong Yang, Yan-Yu Yu, Jia-Kuo Front Chem Chemistry Repair of hyaline cartilage remains a huge challenge in clinic because of the avascular and aneural characteristics and the paucity of endogenous repair cells. Recently, tissue engineering technique, possessing unique capacity of repairing large tissue defects, avoiding donor complications and two-stage invasive surgical procedures, has been developed a promising therapeutic strategy for cartilage injury. In this study, we incorporated low-molecular-weight heparin (LMWH) into carboxymethyl chitosan-oxidized chondroitin sulfate (CMC-OCS) hydrogel for loading transforming growth factor-β3 (TGF-β3) as matrix of peripheral blood mesenchymal stem cells (PB-MSCs) to construct tissue-engineered cartilage. Meanwhile, three control hydrogels with or without LMWH and/or TGF-β3 were also prepared. The gelling time, microstructures, mechanical properties, degradation rate, cytotoxicity, and the release of TGF-β3 of different hydrogels were investigated. In vitro experiments evaluated the tri-lineage differentiation potential of PB-MSCs, combined with the proliferation, distribution, viability, morphology, and chondrogenic differentiation. Compared with non-LMWH-hydrogels, LMWH-hydrogels (LMWH-CMC-OCS-TGF-β3) have shorter gelling time, higher mechanical strength, slower degradation rate and more stable and lasting release of TGF-β3. After two weeks of culture in vitro, expression of cartilage-specific genes collagen type-2 (COL-2) and aggrecan (AGC), and secretion of glycosaminoglycan (GAG), and COL-2 proteins in LMWH-CMC-OCS-TGF-β3 group were significantly higher than those in other groups. COL-2 immunofluorescence staining showed that the proportion of COL-2 positive cells and immunofluorescence intensity in LMWH-CMC-OCS-TGF-β3 hydrogel were significantly higher than those in other groups. The LMWH-CMC-OCS-TGF-β3 hydrogel can slowly release TGF-β3 in a long term, and meanwhile the hydrogel can provide a biocompatible microenvironment for the growth and chondrogenic differentiation of PB-MSCs. Thus, LMWH functionalized CMC-OCS hydrogels proposed in this work will be beneficial for constructing functional scaffolds for tissue-engineered cartilage. Frontiers Media S.A. 2019-11-01 /pmc/articles/PMC6839338/ /pubmed/31737612 http://dx.doi.org/10.3389/fchem.2019.00745 Text en Copyright © 2019 Chen, Zhou, Zhang, Yuan, Xu, Guan, Han, Jiang, Yang and Yu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Chen, You-Rong
Zhou, Zhu-Xing
Zhang, Ji-Ying
Yuan, Fu-Zhen
Xu, Bing-Bing
Guan, Jian
Han, Chao
Jiang, Dong
Yang, Yan-Yu
Yu, Jia-Kuo
Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation
title Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation
title_full Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation
title_fullStr Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation
title_full_unstemmed Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation
title_short Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and in vitro Neocartilage Formation
title_sort low-molecular-weight heparin-functionalized chitosan-chondroitin sulfate hydrogels for controlled release of tgf-β3 and in vitro neocartilage formation
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839338/
https://www.ncbi.nlm.nih.gov/pubmed/31737612
http://dx.doi.org/10.3389/fchem.2019.00745
work_keys_str_mv AT chenyourong lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT zhouzhuxing lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT zhangjiying lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT yuanfuzhen lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT xubingbing lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT guanjian lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT hanchao lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT jiangdong lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT yangyanyu lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation
AT yujiakuo lowmolecularweightheparinfunctionalizedchitosanchondroitinsulfatehydrogelsforcontrolledreleaseoftgfb3andinvitroneocartilageformation